We have located links that may give you full text access.
Comment
Journal Article
Leveraging Molecular Data Analysis to Understand Drug Response in Systemic Sclerosis.
Journal of Investigative Dermatology 2017 May
Taroni et al. integrate and analyze genomic information generated from different clinical trials on systemic sclerosis, a disease for which there is yet no Food and Drug Administration-approved therapy. By using a recent network analysis approach based on tissue-specific functionality, they leverage the biological information extracted from molecular profiling studies and report findings that could be useful for patient stratification.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app